- Home
- BWBBP vs GNLX Comparison
BWBBP vs GNLX Comparison
Compare BWBBP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWBBP
- GNLX
- Stock Information
- Founded
- BWBBP N/A
- GNLX 2001
- Country
- BWBBP United States
- GNLX United States
- Employees
- BWBBP 258
- GNLX N/A
- Industry
- BWBBP Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- BWBBP Finance
- GNLX Health Care
- Exchange
- BWBBP Nasdaq
- GNLX Nasdaq
- Market Cap
- BWBBP N/A
- GNLX 103.6M
- IPO Year
- BWBBP N/A
- GNLX 2023
- Fundamental
- Price
- BWBBP $18.67
- GNLX $2.27
- Analyst Decision
- BWBBP
- GNLX Strong Buy
- Analyst Count
- BWBBP 0
- GNLX 4
- Target Price
- BWBBP N/A
- GNLX $18.25
- AVG Volume (30 Days)
- BWBBP N/A
- GNLX 141.5K
- Earning Date
- BWBBP N/A
- GNLX 11-14-2024
- Dividend Yield
- BWBBP N/A
- GNLX N/A
- EPS Growth
- BWBBP N/A
- GNLX N/A
- EPS
- BWBBP N/A
- GNLX N/A
- Revenue
- BWBBP N/A
- GNLX $8,000.00
- Revenue This Year
- BWBBP N/A
- GNLX N/A
- Revenue Next Year
- BWBBP N/A
- GNLX N/A
- P/E Ratio
- BWBBP N/A
- GNLX N/A
- Revenue Growth
- BWBBP N/A
- GNLX N/A
- 52 Week Low
- BWBBP N/A
- GNLX $1.60
- 52 Week High
- BWBBP N/A
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- BWBBP 40.48
- GNLX 38.68
- Support Level
- BWBBP $18.40
- GNLX $2.13
- Resistance Level
- BWBBP $19.09
- GNLX $2.80
- Average True Range (ATR)
- BWBBP 0.35
- GNLX 0.20
- MACD
- BWBBP -0.03
- GNLX -0.04
- Stochastic Oscillator
- BWBBP 18.72
- GNLX 14.21
About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.